Dendrimers as Nanocarriers for the Delivery of Drugs Obtained from Natural Products
暂无分享,去创建一个
Nani Wang | Pingcui Xu | H. An | Xuehui Deng | Fang Wang
[1] Wen Zhang,et al. Strategies and Lessons Learned from Total Synthesis of Taxol. , 2023, Chemical reviews.
[2] A. Goel. Current understanding and future prospects on Berberine for anticancer therapy , 2023, Chemical biology & drug design.
[3] A. Banerjee,et al. A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation , 2023, Archivum Immunologiae et Therapiae Experimentalis.
[4] Moein Askarpour,et al. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. , 2023, Cytokine.
[5] M. Najafi,et al. Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression , 2023, Clinical and experimental pharmacology & physiology.
[6] Gang Fan,et al. Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies , 2023, International journal of molecular sciences.
[7] Wei Wang,et al. Possible Mechanisms of Oxidative Stress-Induced Skin Cellular Senescence, Inflammation, and Cancer and the Therapeutic Potential of Plant Polyphenols , 2023, International journal of molecular sciences.
[8] G. Sethi,et al. Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements , 2023, Pharmaceutics.
[9] D. Barreca,et al. Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms , 2023, International journal of molecular sciences.
[10] M. Guo,et al. Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems , 2023, Pharmaceutics.
[11] Boyuan Zhang,et al. The current scenario of naturally occurring indole alkaloids with anticancer potential. , 2023, Fitoterapia.
[12] M. Portillo,et al. Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes , 2023, Frontiers in Nutrition.
[13] A. Emwas,et al. Alkaloids as potential antivirals. A comprehensive review , 2023, Natural Products and Bioprospecting.
[14] H. K. Dewangan,et al. Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell , 2022, Journal of biomaterials science. Polymer edition.
[15] Xuyang Gao,et al. New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties. , 2022, European journal of pharmacology.
[16] W. Liu,et al. Pharmacological Activity of Quercetin: An Updated Review , 2022, Evidence-based complementary and alternative medicine : eCAM.
[17] L. Grumetto,et al. Recent Advances in Natural Polyphenol Research , 2022, Molecules.
[18] D. Osinová,et al. Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity , 2022, International journal of molecular sciences.
[19] S. Fouladdel,et al. Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells , 2022, Asian Pacific journal of cancer prevention : APJCP.
[20] Zhidan Liu,et al. A review of plant antipathogenic constituents: Source, activity and mechanism. , 2022, Pesticide biochemistry and physiology.
[21] Zhongyu Zhang,et al. Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease , 2022, Molecules.
[22] Xiaoyong Zhang,et al. Facile synthesis of curcumin-containing poly(amidoamine) dendrimers as pH-responsive delivery system for osteoporosis treatment. , 2022, Colloids and surfaces. B, Biointerfaces.
[23] T. Emran,et al. A spotlight on alkaloid nanoformulations for the treatment of lung cancer , 2022, Frontiers in Oncology.
[24] P. Dalerba,et al. Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis , 2022, Advanced science.
[25] A. All,et al. Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics. , 2022, Small.
[26] E. Moghimipour,et al. Ocular Delivery of Quercetin Using Microemulsion System: Design, Characterization, and Ex-vivo Transcorneal Permeation , 2022, Iranian journal of pharmaceutical research : IJPR.
[27] H. Yang,et al. Dendrimer-based drug delivery systems: history, challenges, and latest developments , 2022, Journal of Biological Engineering.
[28] Yunjian Zhang,et al. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review , 2022, Molecules.
[29] R. Dinarvand,et al. Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds , 2022, Frontiers in Chemistry.
[30] Asghar Narmani,et al. Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer , 2022, Biomedical Engineering Letters.
[31] P. Bharatam,et al. Drug-dendrimer complexes and conjugates: Detailed furtherance through theory and experiments. , 2022, Advances in colloid and interface science.
[32] Yaseen Hussain,et al. Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications , 2022, Antibiotics.
[33] V. Garg,et al. Gallic acid: a dietary polyphenol that exhibits anti-neoplastic activities by modulating multiple oncogenic targets. , 2021, Anti-cancer agents in medicinal chemistry.
[34] Linjie Huang,et al. Gallic Acid: A Potential Anti-Cancer Agent , 2021, Chinese Journal of Integrative Medicine.
[35] M. Martínez-García,et al. Click reaction in the synthesis of dendrimer drug-delivery systems. , 2021, Current Medicinal Chemistry.
[36] D. Kohtz,et al. Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines , 2021, Molecules.
[37] A. Mishra,et al. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin , 2021, Drug Research.
[38] Xiangyang Shi,et al. Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine. , 2021, Journal of Controlled Release.
[39] G. Orive,et al. Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise. , 2021, European journal of medicinal chemistry.
[40] I. Mourtzinos,et al. Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications , 2021, Plants.
[41] M. Farzaei,et al. Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review , 2021, Biomedicines.
[42] L. Barros,et al. Phenolic compounds: current industrial applications, limitations and future challenges. , 2020, Food & function.
[43] M. Sadeghizadeh,et al. Mitochondria-Targeted Polyamidoamine Dendrimer-Curcumin Construct for Hepatocellular Cancer Treatment. , 2020, Molecular pharmaceutics.
[44] Gurinder Singh. Resveratrol: nanocarrier-based delivery systems to enhance its therapeutic potential. , 2020, Nanomedicine.
[45] Zhenzhong Wang,et al. Berberine: a Promising Natural Isoquinoline Alkaloid for Development of Hypolipidemic Drug. , 2020, Current topics in medicinal chemistry.
[46] L. Rus,et al. Applications and Limitations of Dendrimers in Biomedicine , 2020, Molecules.
[47] Ajay Kumar,et al. Surface modified PAMAM dendrimers with gallic acid inhibit, cell proliferation, cell migration and inflammatory response to augment apoptotic cell death in human colon carcinoma cells , 2020, Journal of biomolecular structure & dynamics.
[48] David John Adams,et al. N-acetyl-D-glucosamine-conjugated PAMAM Dendrimers as Dual Receptor-Targeting Nanocarriers for Anticancer Drug Delivery. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[49] M. Miao,et al. Characterizations and bioavailability of dendrimer-like glucan nanoparticulate system containing resveratrol. , 2020, Journal of agricultural and food chemistry.
[50] M. Tso,et al. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[51] B. Ghosh,et al. Cell-Penetrating Peptide and α-Tocopherol-Conjugated Poly(amidoamine) Dendrimers for Improved Delivery and Anticancer Activity of Loaded Paclitaxel. , 2020, ACS applied bio materials.
[52] Zhuxian Zhou,et al. Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors. , 2020, ACS nano.
[53] B. Salehi,et al. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases , 2020, Journal of clinical medicine.
[54] P. Kesharwani,et al. Curcumin loaded poly (amidoamine) dendrimer-plamitic acid core-shell nanoparticles as anti-stress therapeutics , 2020, Drug development and industrial pharmacy.
[55] Michael R Hamblin,et al. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. , 2019, Colloids and surfaces. B, Biointerfaces.
[56] F. Veiga,et al. Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications , 2019, Materials.
[57] V. Torchilin,et al. Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel. , 2019, Nanomedicine.
[58] A. Ramazani,et al. pH-sensitive magnetite nanoparticles modified with hyperbranched polymers and folic acid for targeted imaging and therapy. , 2019, Current drug delivery.
[59] N. Ward,et al. Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review. , 2019, Current vascular pharmacology.
[60] Hu Yang,et al. Drug-Conjugated Dendrimer Hydrogel Enables Sustained Drug Release via a Self-Cleaving Mechanism. , 2019, Molecular pharmaceutics.
[61] B. Ghosh,et al. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy. , 2019, Molecular pharmaceutics.
[62] B. Ghosh,et al. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer , 2019, International journal of pharmaceutics.
[63] Carola Díaz,et al. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin , 2018, Pharmaceutical development and technology.
[64] B. Ghosh,et al. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer , 2018, Artificial cells, nanomedicine, and biotechnology.
[65] H. Danafar,et al. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells , 2018, Drug development and industrial pharmacy.
[66] Y. Yao,et al. Octenylsuccinate hydroxypropyl phytoglycogen, a dendrimer-like biopolymer, solubilizes poorly water-soluble active pharmaceutical ingredients. , 2018, Carbohydrate polymers.
[67] Marwa Masoud,et al. Gallic acid–PAMAM and gallic acid–phospholipid conjugates, physicochemical characterization and in vivo evaluation , 2018, Pharmaceutical development and technology.
[68] Xiao Zheng,et al. Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine , 2018, Drug delivery.
[69] Yi Sun,et al. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate , 2017, Drug delivery.
[70] Chen Gao,et al. In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells. , 2017, International journal of pharmaceutics.
[71] M. P. Khinchi,et al. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics. , 2017, International journal of pharmaceutics.
[72] V. Yellepeddi,et al. Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells. , 2017, Macromolecular bioscience.
[73] Ziying Li,et al. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells. , 2017, Materials science & engineering. C, Materials for biological applications.
[74] Sonam Choudhary,et al. Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules , 2017, Front. Pharmacol..
[75] Mohammad Ramezani,et al. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. , 2017, International journal of pharmaceutics.
[76] Z. Gu,et al. Enzyme-Sensitive and Amphiphilic PEGylated Dendrimer-Paclitaxel Prodrug-Based Nanoparticles for Enhanced Stability and Anticancer Efficacy. , 2017, ACS applied materials & interfaces.
[77] O. Yesil‐Celiktas,et al. Synthesis of silica-PAMAM dendrimer nanoparticles as promising carriers in Neuro blastoma cells. , 2017, Analytical biochemistry.
[78] G. Velderrain‐Rodríguez,et al. Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds. , 2017, Food & function.
[79] S. Mutalik,et al. Skin Delivery of EGCG and Silibinin: Potential of Peptide Dendrimers for Enhanced Skin Permeation and Deposition , 2017, AAPS PharmSciTech.
[80] A. Chauhan,et al. Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology , 2017, Molecules.
[81] Hongmei Jiang,et al. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes , 2016, Mediators of inflammation.
[82] N. K. Jain,et al. Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment. , 2016, Journal of colloid and interface science.
[83] Siling Wang,et al. Study on enhanced lymphatic exposure of polyamidoamin-alkali blue dendrimer for paclitaxel delivery and influence of the osmotic pressure on the lymphatic targeting , 2016, Drug delivery.
[84] N. Gamage,et al. Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle , 2016, Journal of nanomedicine & nanotechnology.
[85] Ž. Knez,et al. Polyphenols: Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects , 2016, Molecules.
[86] Mauro F. A. Adamo,et al. New Dendrimer-Based Nanoparticles Enhance Curcumin Solubility , 2016, Planta Medica.
[87] Yulong Yin,et al. Quercetin, Inflammation and Immunity , 2016, Nutrients.
[88] V. Lather,et al. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid , 2016, Drug delivery.
[89] V. Verma,et al. Role of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data , 2015, Orthopaedic surgery.
[90] R. Bei,et al. In Vitro and in Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment , 2015, International journal of molecular sciences.
[91] A. Caminade,et al. Dendrimers for drug delivery. , 2014, Journal of materials chemistry. B.
[92] J. Ong,et al. Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells. , 2014, Molecular pharmaceutics.
[93] S. Pricl,et al. Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer. , 2014, Journal of medicinal chemistry.
[94] Keerti Jain,et al. Dendrimer as nanocarrier for drug delivery , 2014 .
[95] V. Křen,et al. Biotransformation of silybin and its congeners. , 2013, Current drug metabolism.
[96] Huan He,et al. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin , 2013, Pharmaceutical development and technology.
[97] Jiye Shi,et al. Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells , 2013, Journal of Materials Science: Materials in Medicine.
[98] M. Inglés,et al. [Resveratrol: distribution, properties and perspectives]. , 2013, Revista espanola de geriatria y gerontologia.
[99] A. D'emanuele,et al. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. , 2013, International journal of pharmaceutics.
[100] R. O'Regan,et al. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy , 2012, Chemotherapy research and practice.
[101] N. K. Jain,et al. Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates , 2012, Journal of drug targeting.
[102] D. Wallace. Mitochondria and cancer , 2012, Nature Reviews Cancer.
[103] M Ferrari,et al. Nanovector delivery of siRNA for cancer therapy , 2012, Cancer Gene Therapy.
[104] Yiyun Cheng,et al. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities. , 2011, International journal of pharmaceutics.
[105] Kaoxiang Sun,et al. Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[106] Kaoxiang Sun,et al. Determination of puerarin in rabbit aqueous humor by liquid chromatography tandem mass spectrometry using microdialysis sampling after topical administration of puerarin PAMAM dendrimer complex. , 2011, Journal of pharmaceutical and biomedical analysis.
[107] Xing Tang,et al. Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats , 2011, AAPS PharmSciTech.
[108] Anupama Sharma,et al. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery. , 2011, Bioorganic & medicinal chemistry.
[109] Qin Chen,et al. Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin , 2011, Drug development and industrial pharmacy.
[110] N. K. Jain,et al. Development and characterization of triazine based dendrimers for delivery of antitumor agent. , 2010, Journal of nanoscience and nanotechnology.
[111] Kaoxiang Sun,et al. Preparation and characterization of puerarin–dendrimer complexes as an ocular drug delivery system , 2010, Drug development and industrial pharmacy.
[112] Na Liang,et al. Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin. , 2010, Biological & pharmaceutical bulletin.
[113] A. Ray,et al. PAMAM-Camptothecin Conjugate Inhibits Proliferation and Induces Nuclear Fragmentation in Colorectal Carcinoma Cells , 2010, Pharmaceutical Research.
[114] C. Kang,et al. Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells , 2010, Technology in cancer research & treatment.
[115] F. Szoka,et al. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. , 2009, Molecular pharmaceutics.
[116] M. Clifford,et al. Dietary phenolics: chemistry, bioavailability and effects on health. , 2009, Natural product reports.
[117] Hye-Seon Choi,et al. Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. , 2008, Molecules and cells.
[118] Lie-Chwen Lin,et al. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. , 2007, Journal of pharmaceutical and biomedical analysis.
[119] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[120] N. Vorsa,et al. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. , 2006, Bioconjugate chemistry.
[121] Jianjun Cheng,et al. Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice , 2006, Cancer Chemotherapy and Pharmacology.
[122] Daniel Normolle,et al. Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.
[123] T. Walle,et al. HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.
[124] Kinam Park,et al. Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel. , 2004, Bioconjugate chemistry.
[125] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[126] M. Majeed,et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.
[127] R. Kuttan,et al. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. , 1992, Indian journal of physiology and pharmacology.
[128] Yixin Zhou,et al. Efficacy and side effect of curcumin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. , 2019, Pakistan journal of pharmaceutical sciences.
[129] Youqing Shen,et al. Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. , 2017, Small.
[130] D. Kroetz,et al. Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review , 2017, Clinical Pharmacokinetics.
[131] A. Akbarzadeh,et al. PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[132] Kaoxiang Sun,et al. [Corneal penetration of PAMAM dendrimers-coated puerarin liposomes]. , 2010, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[133] Gary Williamson,et al. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.